Theileriosis is a blood piroplasmic disease that adversely affects the livestock industry, especially in tropical and sub-tropical countries. It is caused by haemoprotozoan of the Theileria genus, transmitted by hard ticks and which possesses a complex life cycle. The clinical course of the disease ranges from benign to lethal, but subclinical infections can occur depending on the infecting Theileria species. The main clinical and clinicopathological manifestations of acute disease include fever, lymphadenopathy, anorexia and severe loss of condition, conjunctivitis, and pale mucous membranes that are associated with Theileria-induced immune-mediated haemolytic anaemia and/or non-regenerative anaemia. Additionally, jaundice, increases in hepatic enzymes, and variable leukocyte count changes are seen. Theileria annulata and Theileria parva induce an incomplete transformation of lymphoid and myeloid cell lineages, and these cells possess certain phenotypes of cancer cells. Pathogenic genotypes of Theileria orientalis have been recently associated with severe production losses in Southeast Asia and some parts of Europe. The infection and treatment method (ITM) is currently used in the control and prevention of T. parva infection, and recombinant vaccines are still under evaluation. The use of gene gun immunization against T. parva infection has been recently evaluated. This review, therefore, provides an overview of the clinicopathological and immunopathological profiles of Theileria-infected cattle and focus on DNA vaccines consisting of plasmid DNA with genes of interest, molecular adjuvants, and chitosan as the most promising next-generation vaccine against bovine theileriosis.

Gastrointestinal nematodes (GIN) pose an existential threat to small ruminants such as sheep and goats (Hoste et al., 2010). The two species have evolved different strategies to minimise the threat (Hoste et al., 2008). In sheep, the immune response is the major mechanism of defence (McRae et al., 2015). The nematode Teladorsagia circumcincta is the dominant nematode in cool temperate areas of the world and possibly there is more known about the mechanisms of protective immunity to this nematode than any other (Stear et al., 1995). There are three major signs of immunity (Smith et al., 1984). The first is reduced establishment and survival which is strongly associated with a local type 1 hypersensitivity response (Miller, 1984; Murphy et al., 2010; Stear et al., 1995). The second sign of resistance is an increased number of inhibited larvae which has been weakly associated with a local IgA response (Smith et al., 1985; Strain et al., 2002) although there is some doubt as to whether the IgA response is quick enough to influence larval inhibition (Halliday et al., 2010). Further, larval inhibition can also be influenced by density-dependent Research paper Boer goats appear to lack a functional IgA and eosinophil response against natural nematode infection Basripuzi (Basripuzi is the surname of the first author.

Understanding the structure of the major histocompatibility complex, especially the number and frequency of alleles, loci and haplotypes, is crucial for efficient investigation of the way in which the MHC influences susceptibility to disease. Nematode infection is one of the most important diseases suffered by sheep, and the class II region has been repeatedly associated with differences in susceptibility and resistance to infection. Texel sheep are widely used in many different countries and are relatively resistant to infection. This study determined the number and frequency of MHC class II genes in a small flock of Texel sheep. There were 18 alleles at DRB1, 9 alleles at DQA1, 13 alleles at DQB1, 8 alleles at DQA2 and 16 alleles at DQB2. Several haplotypes had no detectable gene products at DQA1, DQB1 or DQB2, and these were defined as null alleles. Despite the large numbers of alleles, there were only 21 distinct haplotypes in the population. The relatively small number of observed haplotypes will simplify finding disease associations because common haplotypes provide more statistical power but complicate the discrimination of causative mutations from linked marker loci.Electronic supplementary materialThe online version of this article (doi:10.1007/s00251-016-0962-6) contains supplementary material, which is available to authorized users.

Rumen fluke is a parasitosis that infects ruminant animals across a wide geographical range of countries. It is a severe infection in temperate and tropical climate regions of Asia, Australia, Africa, and Europe, which cause significant economic losses. In this review, the available information to date on rumen fluke species infecting cattle and buffaloes in Asian countries is evaluated. The citation search was performed through specific keywords, literature published from 1964 to 2021, retrieved from electronic databases: Scopus, Web of Science, Pub Med, Education Resources Information Center (ERIC), Science Direct, Elsevier, and Google Scholar. Twenty-six (26) rumen fluke species belonging to two families: Paramphistomidae 61.5% (16/26) and Gastrothylacidae 38.4% (10/26), were reported in cattle and buffaloes in fourteen Asian countries. Paramphistomum cervi and Cotylophoron cotylophorum are the most prevalent species with broader distribution in countries than the other genera. The coprological prevalence varies from 0.8% to 98.17% and 0.86% to 78.4% in cattle and buffaloes, respectively. The prevalence of rumen fluke by fluke counts method range between 6.45% to 90.6% and 4.29% to 75.07% in cattle and buffaloes, respectively. The sedimentation method and fluke count are reliable tests for detecting rumen fluke in live and slaughtered animals. In conclusion, the rumen fluke should be considered a critical production disease that affects cattle and buffaloes in Asia. Further studies are necessary to determine the rumen fluke-snail associations, develop diagnostic tests to detect prepatent infections in the definitive host, determine the economic importance of rumen fluke, and determine the efficacy of different anthelmintic in the treatment of patent infections in the definitive host.